organic compounds\(\def\hfill{\hskip 5em}\def\hfil{\hskip 3em}\def\eqno#1{\hfil {#1}}\)

Journal logoCRYSTALLOGRAPHIC
COMMUNICATIONS
ISSN: 2056-9890

3-(2,4-Di­chloro­phen­yl)-5-methyl-1,2,4-oxa­diazole

aX-ray Crystallography Unit, School of Physics, Universiti Sains Malaysia, 11800 USM, Penang, Malaysia, bSyngene International Ltd, Biocon Park, Plot Nos 2 & 3, Bommasandra 4th Phase, Jigani Link Rd, Bangalore 560100, India, cDepartment of Chemistry, Organic Chemistry Division, National Institute of Technology-Karnataka, Surathkal, Mangalore 575 025, India, and dDepartment of Printing, Manipal Institute of Technology, Manipal 576 104, India
*Correspondence e-mail: hkfun@usm.my

(Received 24 February 2010; accepted 2 March 2010; online 6 March 2010)

In the title compound, C9H6Cl2N2O, the dihedral angle between the oxadiazole and benzene rings is 1.7 (2)°. In the crystal, the mol­ecules are linked into chains along the b axis by short inter­molecular Cl⋯O contacts [3.019 (3) Å].

Related literature

For general background and the biological activity of oxa­diazole compounds, see: Andersen et al. (1994[Andersen, K. E., Jørgensen, A. S. & Bræstrup, C. (1994). Eur. J. Med. Chem. 29, 393-399.]); Clitherow et al. (1996[Clitherow, J. W., Beswick, P., Irving, W. J., Scopes, D. I. C., Barnes, J. C., Clapham, J., Brown, J. D., Evans, D. J. & Hayes, A. G. (1996). Bioorg. Med. Chem. Lett. 6, 833-838.]); Showell et al. (1991[Showell, G. A., Gibbons, T. L., Kneen, C. O., MacLeod, A. M., Merchant, K., Saunders, J., Freedman, S. B., Patel, S. & Baker, R. (1991). J. Med. Chem. 34, 1086-1094.]); Swain et al. (1991[Swain, C. J., Baker, R., Kneen, C., Moseley, J., Saunders, J., Seward, E. M., Stevenson, G., Beer, M., Stanton, J. & Watling, K. (1991). J. Med. Chem. 34, 140-151.]); Watjen et al. (1989[Watjen, F., Baker, R., Engelstoff, M., Herbert, R., MacLeod, A., Knight, A., Merchant, K., Moseley, J., Saunders, J., Swain, C. J., Wang, E. & Springer, J. P. (1989). J. Med. Chem. 32, 282-2291.]). For a related structure, see: Wang et al. (2006[Wang, H.-B., Liu, Z.-Q., Wang, H.-B. & Yan, X.-C. (2006). Acta Cryst. E62, o4715-o4716.]). For the stability of the temperature controller used for the data collection, see: Cosier & Glazer (1986[Cosier, J. & Glazer, A. M. (1986). J. Appl. Cryst. 19, 105-107.]).

[Scheme 1]

Experimental

Crystal data
  • C9H6Cl2N2O

  • Mr = 229.06

  • Monoclinic, P 21 /c

  • a = 3.8252 (7) Å

  • b = 21.678 (4) Å

  • c = 11.0833 (19) Å

  • β = 92.421 (4)°

  • V = 918.3 (3) Å3

  • Z = 4

  • Mo Kα radiation

  • μ = 0.67 mm−1

  • T = 100 K

  • 0.28 × 0.17 × 0.11 mm

Data collection
  • Bruker SMART APEXII CCD area-detector diffractometer

  • Absorption correction: multi-scan (SADABS; Bruker, 2005[Bruker (2005). APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.]) Tmin = 0.833, Tmax = 0.929

  • 7920 measured reflections

  • 2076 independent reflections

  • 1709 reflections with I > 2σ(I)

  • Rint = 0.048

Refinement
  • R[F2 > 2σ(F2)] = 0.056

  • wR(F2) = 0.155

  • S = 1.20

  • 2076 reflections

  • 128 parameters

  • H-atom parameters constrained

  • Δρmax = 0.72 e Å−3

  • Δρmin = −0.56 e Å−3

Data collection: APEX2 (Bruker, 2005[Bruker (2005). APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.]); cell refinement: SAINT (Bruker, 2005[Bruker (2005). APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.]); data reduction: SAINT; program(s) used to solve structure: SHELXTL (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); program(s) used to refine structure: SHELXTL; molecular graphics: SHELXTL; software used to prepare material for publication: SHELXTL and PLATON (Spek, 2009[Spek, A. L. (2009). Acta Cryst. D65, 148-155.]).

Supporting information


Comment top

Heterocyclic compounds are important in recent years due to pharmacological activities. Nitrogen, oxygen containing five- and six-membered heterocyclic compounds have enormous significance in the field of medicinal chemistry. Oxadiazoles play a very vital role in the preparation of various biologically active drugs with anti-inflammatory (Andersen et al., 1994), anti-cancer (Showell et al., 1991), anti-HIV (Watjen et al., 1989), anti-diabetic and anti-microbial (Swain et al., 1991) properties. The results of biological studies showed that oxadiazole derivatives are molecules with maximum anti-inflammatory, analgesic and minimum ulcerogenic and lipid per-oxidation (Clitherow et al., 1996) properties.

Bond lengths and angles are normal (Wang et al., 2006). The mean plane of the oxadiazole ring (C1/C2/N1/N2/O1) is almost coplanar with the mean plane of the C3–C8 benzene ring (Fig. 1), with a dihedral angle of 1.7 (2)°.

The molecules are linked by Cl2···O1(-x, 1/2+y, 3/2-z) short contacts [3.019 (3) Å;] to form chains along the b axis (Fig.2).

Related literature top

For general background and the biological activity of oxadiazole compounds, see: Andersen et al. (1994); Clitherow et al. (1996); Showell et al. (1991); Swain et al. (1991); Watjen et al. (1989). For a related structure, see: Wang et al. (2006). For the stability of the temperature controller used for the data collection, see: Cosier & Glazer (1986).

Experimental top

The title compound was prepared by heating a solution of 2,4-dichloro-N'-hydroxy-benzamidine (1 g, 0.0042 mol) and acetyl chloride (0.38 g, 0.004 mol) in pyridine (30 ml) at 387 K for 1.5 h and the contents were concentrated under vacuum. Further purification was done by column chromatography. The solid obtained was recrystallized using dichloromethane (yield: 1.0 g (76%); m.p. 371-372 K).

Refinement top

H atoms were placed in calculated positions [C–H = 0.93–0.96 Å] and refined as riding with Uiso(H) = 1.2eq(C) or 1.5Ueq(methyl C). A rotating group model was used for the methyl group.

Computing details top

Data collection: APEX2 (Bruker, 2005); cell refinement: SAINT (Bruker, 2005); data reduction: SAINT (Bruker, 2005); program(s) used to solve structure: SHELXTL (Sheldrick, 2008); program(s) used to refine structure: SHELXTL (Sheldrick, 2008); molecular graphics: SHELXTL (Sheldrick, 2008); software used to prepare material for publication: SHELXTL (Sheldrick, 2008) and PLATON (Spek, 2009).

Figures top
[Figure 1] Fig. 1. The molecular structure of the title compound, showing 50% probability displacement ellipsoids and the atom-numbering scheme.
[Figure 2] Fig. 2. The crystal structure of the title compound, showing chains along the b axis.
3-(2,4-Dichlorophenyl)-5-methyl-1,2,4-oxadiazole top
Crystal data top
C9H6Cl2N2OF(000) = 464
Mr = 229.06Dx = 1.657 Mg m3
Monoclinic, P21/cMo Kα radiation, λ = 0.71073 Å
Hall symbol: -P 2ybcCell parameters from 3719 reflections
a = 3.8252 (7) Åθ = 2.6–31.1°
b = 21.678 (4) ŵ = 0.67 mm1
c = 11.0833 (19) ÅT = 100 K
β = 92.421 (4)°Block, colourless
V = 918.3 (3) Å30.28 × 0.17 × 0.11 mm
Z = 4
Data collection top
Bruker SMART APEXII CCD area-detector
diffractometer
2076 independent reflections
Radiation source: fine-focus sealed tube1709 reflections with I > 2σ(I)
Graphite monochromatorRint = 0.048
ϕ and ω scansθmax = 27.5°, θmin = 1.9°
Absorption correction: multi-scan
(SADABS; Bruker, 2005)
h = 44
Tmin = 0.833, Tmax = 0.929k = 2628
7920 measured reflectionsl = 1314
Refinement top
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.056Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.155H-atom parameters constrained
S = 1.20 w = 1/[σ2(Fo2) + (0.0428P)2 + 4.0517P]
where P = (Fo2 + 2Fc2)/3
2076 reflections(Δ/σ)max = 0.001
128 parametersΔρmax = 0.72 e Å3
0 restraintsΔρmin = 0.56 e Å3
Crystal data top
C9H6Cl2N2OV = 918.3 (3) Å3
Mr = 229.06Z = 4
Monoclinic, P21/cMo Kα radiation
a = 3.8252 (7) ŵ = 0.67 mm1
b = 21.678 (4) ÅT = 100 K
c = 11.0833 (19) Å0.28 × 0.17 × 0.11 mm
β = 92.421 (4)°
Data collection top
Bruker SMART APEXII CCD area-detector
diffractometer
2076 independent reflections
Absorption correction: multi-scan
(SADABS; Bruker, 2005)
1709 reflections with I > 2σ(I)
Tmin = 0.833, Tmax = 0.929Rint = 0.048
7920 measured reflections
Refinement top
R[F2 > 2σ(F2)] = 0.0560 restraints
wR(F2) = 0.155H-atom parameters constrained
S = 1.20Δρmax = 0.72 e Å3
2076 reflectionsΔρmin = 0.56 e Å3
128 parameters
Special details top

Experimental. The crystal was placed in the cold stream of an Oxford Cyrosystems Cobra open-flow nitrogen cryostat (Cosier & Glazer, 1986) operating at 100.0 (1) K.

Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.

Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > 2sigma(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2) top
xyzUiso*/Ueq
Cl10.2530 (2)0.40084 (4)0.92173 (8)0.0163 (2)
Cl20.1238 (3)0.63730 (4)0.78985 (9)0.0185 (3)
O10.2054 (8)0.27327 (13)0.6574 (3)0.0220 (7)
N10.3467 (8)0.35961 (15)0.5636 (3)0.0158 (7)
N20.0709 (10)0.32171 (16)0.7322 (3)0.0194 (7)
C10.3637 (11)0.30045 (18)0.5605 (4)0.0173 (8)
C20.1651 (10)0.37119 (18)0.6715 (3)0.0140 (8)
C30.0869 (9)0.43519 (17)0.7088 (3)0.0124 (7)
C40.0928 (10)0.45392 (18)0.8165 (3)0.0137 (8)
C50.1523 (9)0.51553 (18)0.8418 (4)0.0136 (7)
H5A0.26840.52720.91360.016*
C60.0369 (10)0.56000 (17)0.7588 (3)0.0127 (7)
C70.1429 (10)0.54398 (18)0.6533 (4)0.0151 (8)
H7A0.22400.57400.59900.018*
C80.1993 (10)0.48214 (18)0.6303 (4)0.0153 (8)
H8A0.31860.47120.55860.018*
C90.5226 (12)0.2592 (2)0.4666 (4)0.0237 (9)
H9A0.64280.28350.40550.036*
H9B0.68560.23190.50280.036*
H9C0.34220.23540.43080.036*
Atomic displacement parameters (Å2) top
U11U22U33U12U13U23
Cl10.0168 (5)0.0182 (5)0.0138 (5)0.0028 (3)0.0011 (3)0.0023 (4)
Cl20.0197 (5)0.0140 (4)0.0219 (5)0.0024 (3)0.0025 (4)0.0017 (4)
O10.0309 (17)0.0139 (14)0.0213 (15)0.0017 (12)0.0017 (12)0.0018 (12)
N10.0130 (15)0.0175 (16)0.0172 (17)0.0000 (12)0.0018 (12)0.0022 (13)
N20.0257 (19)0.0147 (16)0.0178 (18)0.0002 (14)0.0018 (14)0.0032 (13)
C10.0148 (19)0.0194 (19)0.018 (2)0.0000 (15)0.0051 (15)0.0007 (15)
C20.0103 (17)0.0185 (19)0.0138 (18)0.0022 (14)0.0081 (14)0.0000 (14)
C30.0078 (17)0.0152 (18)0.0150 (18)0.0009 (13)0.0080 (14)0.0011 (14)
C40.0126 (18)0.0171 (19)0.0119 (19)0.0043 (13)0.0054 (14)0.0016 (14)
C50.0070 (16)0.0208 (19)0.0132 (18)0.0017 (14)0.0022 (13)0.0021 (15)
C60.0106 (17)0.0134 (17)0.0144 (18)0.0008 (13)0.0033 (13)0.0027 (14)
C70.0106 (18)0.0174 (19)0.0177 (19)0.0033 (14)0.0056 (14)0.0033 (15)
C80.0114 (17)0.0181 (19)0.017 (2)0.0005 (14)0.0055 (14)0.0004 (15)
C90.025 (2)0.018 (2)0.029 (2)0.0030 (16)0.0041 (18)0.0072 (17)
Geometric parameters (Å, º) top
Cl1—C41.732 (4)C4—C51.382 (5)
Cl2—C61.740 (4)C5—C61.391 (5)
O1—C11.346 (5)C5—H5A0.93
O1—N21.421 (4)C6—C71.376 (5)
N1—C11.285 (5)C7—C81.380 (6)
N1—C21.381 (5)C7—H7A0.93
N2—C21.308 (5)C8—H8A0.93
C1—C91.483 (6)C9—H9A0.96
C2—C31.475 (5)C9—H9B0.96
C3—C81.396 (5)C9—H9C0.96
C3—C41.411 (5)
C1—O1—N2106.4 (3)C6—C5—H5A120.3
C1—N1—C2103.2 (3)C7—C6—C5121.3 (4)
C2—N2—O1102.8 (3)C7—C6—Cl2119.7 (3)
N1—C1—O1113.3 (4)C5—C6—Cl2119.0 (3)
N1—C1—C9129.8 (4)C6—C7—C8118.1 (4)
O1—C1—C9116.9 (4)C6—C7—H7A121.0
N2—C2—N1114.4 (4)C8—C7—H7A121.0
N2—C2—C3125.4 (4)C7—C8—C3123.5 (4)
N1—C2—C3120.2 (3)C7—C8—H8A118.3
C8—C3—C4116.4 (3)C3—C8—H8A118.3
C8—C3—C2117.2 (3)C1—C9—H9A109.5
C4—C3—C2126.4 (3)C1—C9—H9B109.5
C5—C4—C3121.3 (3)H9A—C9—H9B109.5
C5—C4—Cl1117.1 (3)C1—C9—H9C109.5
C3—C4—Cl1121.6 (3)H9A—C9—H9C109.5
C4—C5—C6119.4 (3)H9B—C9—H9C109.5
C4—C5—H5A120.3
C1—O1—N2—C20.1 (4)C8—C3—C4—C50.0 (5)
C2—N1—C1—O10.4 (5)C2—C3—C4—C5179.8 (3)
C2—N1—C1—C9179.1 (4)C8—C3—C4—Cl1179.1 (3)
N2—O1—C1—N10.2 (5)C2—C3—C4—Cl10.6 (5)
N2—O1—C1—C9179.1 (3)C3—C4—C5—C60.8 (6)
O1—N2—C2—N10.4 (4)Cl1—C4—C5—C6178.4 (3)
O1—N2—C2—C3179.3 (3)C4—C5—C6—C71.6 (6)
C1—N1—C2—N20.5 (5)C4—C5—C6—Cl2178.3 (3)
C1—N1—C2—C3179.5 (3)C5—C6—C7—C81.5 (6)
N2—C2—C3—C8178.0 (4)Cl2—C6—C7—C8178.4 (3)
N1—C2—C3—C80.8 (5)C6—C7—C8—C30.7 (6)
N2—C2—C3—C41.8 (6)C4—C3—C8—C70.1 (6)
N1—C2—C3—C4179.4 (4)C2—C3—C8—C7179.7 (4)

Experimental details

Crystal data
Chemical formulaC9H6Cl2N2O
Mr229.06
Crystal system, space groupMonoclinic, P21/c
Temperature (K)100
a, b, c (Å)3.8252 (7), 21.678 (4), 11.0833 (19)
β (°) 92.421 (4)
V3)918.3 (3)
Z4
Radiation typeMo Kα
µ (mm1)0.67
Crystal size (mm)0.28 × 0.17 × 0.11
Data collection
DiffractometerBruker SMART APEXII CCD area-detector
diffractometer
Absorption correctionMulti-scan
(SADABS; Bruker, 2005)
Tmin, Tmax0.833, 0.929
No. of measured, independent and
observed [I > 2σ(I)] reflections
7920, 2076, 1709
Rint0.048
(sin θ/λ)max1)0.650
Refinement
R[F2 > 2σ(F2)], wR(F2), S 0.056, 0.155, 1.20
No. of reflections2076
No. of parameters128
H-atom treatmentH-atom parameters constrained
Δρmax, Δρmin (e Å3)0.72, 0.56

Computer programs: APEX2 (Bruker, 2005), SAINT (Bruker, 2005), SHELXTL (Sheldrick, 2008) and PLATON (Spek, 2009).

 

Footnotes

Thomson Reuters ResearcherID: A-3561-2009.

Acknowledgements

HKF and MMR thank the Malaysian Government and Universiti Sains Malaysia (USM) for the Research University Golden Goose Grant (1001/PFIZIK/811012). AMI is grateful to Professor Sandeep Sancheti, Director, National Institute of Technology-Karnataka, India, for providing research facilities and encouragement.

References

First citationAndersen, K. E., Jørgensen, A. S. & Bræstrup, C. (1994). Eur. J. Med. Chem. 29, 393-399.  CrossRef CAS Web of Science Google Scholar
First citationBruker (2005). APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.  Google Scholar
First citationClitherow, J. W., Beswick, P., Irving, W. J., Scopes, D. I. C., Barnes, J. C., Clapham, J., Brown, J. D., Evans, D. J. & Hayes, A. G. (1996). Bioorg. Med. Chem. Lett. 6, 833–838.  CrossRef CAS Web of Science Google Scholar
First citationCosier, J. & Glazer, A. M. (1986). J. Appl. Cryst. 19, 105–107.  CrossRef CAS Web of Science IUCr Journals Google Scholar
First citationSheldrick, G. M. (2008). Acta Cryst. A64, 112–122.  Web of Science CrossRef CAS IUCr Journals Google Scholar
First citationShowell, G. A., Gibbons, T. L., Kneen, C. O., MacLeod, A. M., Merchant, K., Saunders, J., Freedman, S. B., Patel, S. & Baker, R. (1991). J. Med. Chem. 34, 1086–1094.  CSD CrossRef CAS PubMed Web of Science Google Scholar
First citationSpek, A. L. (2009). Acta Cryst. D65, 148–155.  Web of Science CrossRef CAS IUCr Journals Google Scholar
First citationSwain, C. J., Baker, R., Kneen, C., Moseley, J., Saunders, J., Seward, E. M., Stevenson, G., Beer, M., Stanton, J. & Watling, K. (1991). J. Med. Chem. 34, 140–151.  CrossRef PubMed CAS Web of Science Google Scholar
First citationWang, H.-B., Liu, Z.-Q., Wang, H.-B. & Yan, X.-C. (2006). Acta Cryst. E62, o4715–o4716.  Web of Science CSD CrossRef IUCr Journals Google Scholar
First citationWatjen, F., Baker, R., Engelstoff, M., Herbert, R., MacLeod, A., Knight, A., Merchant, K., Moseley, J., Saunders, J., Swain, C. J., Wang, E. & Springer, J. P. (1989). J. Med. Chem. 32, 282–2291.  CSD CrossRef Web of Science Google Scholar

This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.

Journal logoCRYSTALLOGRAPHIC
COMMUNICATIONS
ISSN: 2056-9890
Follow Acta Cryst. E
Sign up for e-alerts
Follow Acta Cryst. on Twitter
Follow us on facebook
Sign up for RSS feeds